
(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Aurora chaser catches a fox basking in the glow of Finland's legendary 'fox fires' (photos) - 2
SF Chinatown's historic Empress of China building being revived into cultural campus - 3
2026 Golden Globes: How to watch, start time, TV channel, full nominee list and more - 4
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug - 5
These are the Fastest Italian Sports Cars
Step by step instructions to Figure out the Natural Effect of 5G Pinnacles
New 'People We Meet on Vacation' trailer teases Poppy and Alex romance: Everything we know about the new Netflix movie
Instructions to Warmly greet Certainty and Appeal
Huge solar flare no threat to Artemis 2 astronaut launch to the moon, NASA says
Unwinding the Starting points of America: An Excursion Through History
NASA probe captures stunning photos of Earth and moon on the way to infamous asteroid Apophis
Consume Fat Quick: 10 Demonstrated Activities for Ideal Outcomes
7 Methods for further developing Rest Quality
Astronauts on the ISS watched NASA's historic Artemis 2 launch from space













